Citation 142078

KAWAII,S: TOMONO,Y: KATASE,E: OGAWA,K: YANO,M:. (1999). ANTIPROLIFERATIVE ACTIVITY OF FLAVONONDS ON SEVERAL CANCER CELL LINES.. 63(5)

Citation Details

Title	ANTIPROLIFERATIVE ACTIVITY OF FLAVONONDS ON SEVERAL CANCER CELL LINES.
Authors	KAWAII,S: TOMONO,Y: KATASE,E: OGAWA,K: YANO,M:
Year	1999
Volume	63
Issue	5

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
2	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
3	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
4	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
5	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
6	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
7	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
8	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
9	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN	INACTIVE
10	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN	INACTIVE
11	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN	INACTIVE
12	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN	INACTIVE
13	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN	INACTIVE
14	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN	INACTIVE
15	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN	INACTIVE
16	SISTER CHROMATID EXCHANGE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN	INACTIVE
17	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
18	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
19	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
20	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
21	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN,ISO:	INACTIVE
22	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN,ISO:	INACTIVE
23	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN,ISO:	INACTIVE
24	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN,ISO:	INACTIVE
25	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
26	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
27	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
28	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
29	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
30	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
31	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
32	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
33	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
34	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
35	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
36	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
37	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARIRUTIN	INACTIVE
38	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARIRUTIN	INACTIVE
39	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARIRUTIN	INACTIVE
40	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARIRUTIN	INACTIVE
41	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN,NEO:	INACTIVE
42	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN,NEO:	INACTIVE
43	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN,NEO:	INACTIVE
44	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMIN,NEO:	INACTIVE
45	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN,NEO:	INACTIVE
46	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN,NEO:	INACTIVE
47	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN,NEO:	INACTIVE
48	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCITRIN,NEO:	INACTIVE
49	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN,NEO:	INACTIVE
50	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN,NEO:	INACTIVE
51	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN,NEO:	INACTIVE
52	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN,NEO:	INACTIVE
53	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN,NEO:	INACTIVE
54	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN,NEO:	INACTIVE
55	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN,NEO:	INACTIVE
56	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN,NEO:	INACTIVE
57	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN	INACTIVE
58	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN	INACTIVE
59	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN	INACTIVE
60	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PONCIRIN	INACTIVE
61	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN	INACTIVE
62	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN	INACTIVE
63	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN	INACTIVE
64	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHOIFOLIN	INACTIVE
65	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
66	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
67	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
68	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
69	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SINENSETIN	INACTIVE
70	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SINENSETIN	INACTIVE
71	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SINENSETIN	INACTIVE
72	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SINENSETIN	INACTIVE
73	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
74	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
75	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
76	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
77	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
78	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	INACTIVE
79	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
80	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
81	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
82	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
83	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
84	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
85	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
86	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
87	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
88	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	ACTIVE
89	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-5-6-7-8-HEPTAMETHOXY:	INACTIVE
90	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-5-6-7-8-HEPTAMETHOXY:	ACTIVE
91	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-5-6-7-8-HEPTAMETHOXY:	ACTIVE
92	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-5-6-7-8-HEPTAMETHOXY:	ACTIVE
93	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NATSUDAIDAIN	ACTIVE
94	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NATSUDAIDAIN	ACTIVE
95	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NATSUDAIDAIN	ACTIVE
96	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NATSUDAIDAIN	ACTIVE
97	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NOBILETIN	ACTIVE
98	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NOBILETIN	ACTIVE
99	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NOBILETIN	ACTIVE
100	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NOBILETIN	ACTIVE
101	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE
102	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE
103	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE
104	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	ACTIVE

Citation 142078

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1